Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Thrombosis and Haemostasis

• Publication date

  2013-11-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1160/TH13-06-0497PMID 24196490
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Influence of Bolus to Infusion Delays on Plasma Tissue Plasminogen Activator Levels

  2014cited by this paper
• Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass.

  2013cited by this paper
• Treatment of refractory hemorrhage with factor XIII in a patient with hemophilia A with inhibitor

  2013cited by this paper
• A fibrinogen concentrate Haemocomplettan® (Riastap®) or a Factor XIII concentrate Fibrogammin® combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin‐ or FXa‐inhibitor

  2013cited by this paper
• The role of fibrinogen in trauma-induced coagulopathy

  2013cited by this paper
• The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro.

  2013influential reference
• The inhibiting effect of factor XIII on hyperfibrinolysis.

  2012cited by this paper
• Fibrinogen as a Hemostatic Agent

  2012cited by this paper
• Fibrinogen and Hemostasis: A Primary Hemostatic Target for the Management of Acquired Bleeding

  2012cited by this paper
• Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes

  2012cited by this paper
• Factor XIII and Tranexamic Acid But Not Recombinant Factor VIIa Attenuate Tissue Plasminogen Activator–Induced Hyperfibrinolysis in Human Whole Blood

  2012cited by this paper
• Tranexamic acid for trauma patients: a critical review of the literature.

  2011cited by this paper
• Management of major trauma haemorrhage: treatment priorities and controversies

  2011influential reference
• Recent massive blood transfusion practice in England and Wales: view from a trauma registry

  2011cited by this paper
• The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis

  2010cited by this paper
• Prophylactic therapy with Fibrogammin® P is associated with a decreased incidence of bleeding episodes: a retrospective study

  2010cited by this paper
• Management of bleeding following major trauma: an updated European guideline

  2010cited by this paper
• Standardization of thromboelastography: values and challenges.

  2010cited by this paper
• Role of fibrinogen in trauma-induced coagulopathy.

  2010cited by this paper
• In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM®)

  2010influential reference
• Evidence that α2‐antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation

  2008cited by this paper
• The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution

  2008influential reference
• Structure of fibrin: impact on clot stability

  2007cited by this paper
• Thrombin generation, a function test of the haemostaticthrombotic system

  2006cited by this paper
• Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials

  2005cited by this paper
• Fibrinogen and fibrin structure and functions

  2005cited by this paper
• Fibrinopeptides and fibrin gel structure.

  2004cited by this paper
• Plasma Tranexamic Acid Concentrations During Cardiopulmonary Bypass

  2001cited by this paper
• Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

  2000cited by this paper
• Structural studies of fibrinolysis by electron microscopy.

  1998cited by this paper
• Tissue plasminogen activator (tPA) antigen in plasma: correlation with different tPA/inhibitor complexes.

  1998cited by this paper
• A new rapid air-drying technique for scanning electron microscopy using tetramethylsilane: application to mammalian tissue.

  1993cited by this paper
• Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations.

  1988cited by this paper
• Fibrin gel structure and clotting time.

  1982cited by this paper

• Fibrinogen: the higher the better?

  2025cites this paper
• Fibrin Network Porosity and Endo-/Exogenous Thrombin Cross-talk

  2021cites this paper
• The Clotting Trigger Is an Important Determinant for the Coagulation Pathway In Vivo or In Vitro—Inference from Data Review

  2020cites this paper
• Sufficient Thrombin Generation Despite 95% Hemodilution: An In Vitro Experimental Study

  2020cites this paper
• Fibrin clot susceptibility to lysis is impaired after on-pump coronary artery by-pass grafting with tranexamic acid: clinical implications.

  2020cites this paper
• Temporal Changes in Fibrinolysis following Injury

  2020cites this paper
• Fibrinolysis Dysregulation Following Trauma

  2020cites this paper
• Effects of fibrinogen supplementation on clot formation in blood samples from cardiac surgery patients before and after tranexamic acid administration

  2019influential citation
• A CRISP(e)R view on kidney organoids allows generation of an induced pluripotent stem cell-derived kidney model for drug discovery.

  2018cites this paper
• An increased tendency in fibrinogen activity and its association with a hypo-fibrinolytic state in early stages after injury in patients without acute traumatic coagulopathy (ATC)

  2018cites this paper
• Pathophysiological significance of protein hydrophobic interactions: An emerging hypothesis.

  2018cites this paper
• Global impairments in the haemostasis systems after cardiopulmonary bypass.

  2017cites this paper
• Postoperative cerebral bleeding in a boy with suspected mild deficiency of fibrinogen and FXIII.

  2016cites this paper
• Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease

  2016cites this paper
• Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection

  2016cites this paper
• Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage.

  2015cites this paper
• Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation

  2015cites this paper
• Plasma Is the Physiologic Buffer of tPA Mediated Fibrinolysis: Rationale for Plasma First Resuscitation after Life-Threatening Hemorrhage

  2015cites this paper
• Assays of fibrin network properties altered by VKAs in atrial fibrillation – importance of using an appropriate coagulation trigger

  2014influential citation
• Transfusionsmanagement bei Notfall- und Massivtransfusionen

  2014cites this paper
• Intrapartum anti-disseminated intravascular coagulation therapy leading to successful vaginal delivery following intrauterine fetal death caused by placental abruption: a case report

  2014cites this paper